We just received data on a new analyst forecast for $QBTS. N. Quinn Bolton from Needham set a price target of 40.0 for QBTS.
To track analyst ratings and price targets for $QBTS, check out Quiver Quantitative's $QBTS forecast page.
Should you buy $QBTS?
Some analysts are better than others. To view the past performance of Needham, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$QBTS Price Targets
Multiple analysts have issued price targets for $QBTS recently. We have seen 8 analysts offer price targets for $QBTS in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- N. Quinn Bolton from Needham set a target price of $40.0 on 05/13/2026
- Suji Desilva from Roth Capital set a target price of $30.0 on 02/27/2026
- Mark Lipacis from Evercore ISI Group set a target price of $42.0 on 02/27/2026
- Vijay Rakesh from Mizuho set a target price of $40.0 on 02/27/2026
- John McPeake from Rosenblatt set a target price of $43.0 on 01/28/2026
- David Williams from Benchmark set a target price of $35.0 on 01/23/2026
- Antoine Legault from Wedbush set a target price of $35.0 on 12/17/2025
$QBTS Insider Trading Activity
$QBTS insiders have traded $QBTS stock on the open market 25 times in the past 6 months. Of those trades, 1 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $QBTS stock by insiders over the last 6 months:
- ALAN E BARATZ (President & CEO) has made 0 purchases and 3 sales selling 996,827 shares for an estimated $28,791,322.
- JOHN M. MARKOVICH (Chief Financial Officer) has made 0 purchases and 8 sales selling 629,507 shares for an estimated $15,846,675.
- DIANE NGUYEN (EVP, Chief Legal Officer & GC) has made 0 purchases and 7 sales selling 54,038 shares for an estimated $1,380,819.
- ROHIT GHAI has made 0 purchases and 2 sales selling 20,000 shares for an estimated $419,009.
- JOHN D DILULLO has made 0 purchases and 2 sales selling 16,000 shares for an estimated $362,987.
- KIRSTJEN NIELSEN sold 7,000 shares for an estimated $158,340
- SOPHIE C AMES (Exec. Vice President & CHRO) sold 3,070 shares for an estimated $65,548
- STEVEN M WEST purchased 82 shares for an estimated $1,794
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$QBTS Revenue
$QBTS had revenues of $2.9M in Q1 2026. This is a decrease of -80.95% from the same period in the prior year.
You can track QBTS financials on Quiver Quantitative's QBTS stock page.
You can access data on QBTS stock through the Quiver Quantitative API.
$QBTS Hedge Fund Activity
We have seen 265 institutional investors add shares of $QBTS stock to their portfolio, and 252 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. removed 13,555,579 shares (-99.3%) from their portfolio in Q4 2025, for an estimated $354,478,390
- MORGAN STANLEY removed 3,789,768 shares (-59.8%) from their portfolio in Q4 2025, for an estimated $99,102,433
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 3,192,837 shares (-99.9%) from their portfolio in Q1 2026, for an estimated $46,072,637
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,037,038 shares (-66.3%) from their portfolio in Q4 2025, for an estimated $79,418,543
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 2,443,818 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $63,905,840
- BLACKROCK, INC. added 1,997,206 shares (+7.6%) to their portfolio in Q4 2025, for an estimated $52,226,936
- MAREX GROUP PLC added 1,966,500 shares (+74.9%) to their portfolio in Q4 2025, for an estimated $51,423,975
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
